364 related articles for article (PubMed ID: 22125309)
1. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
Saini A; Al-Shanti N; Sharples AP; Stewart CE
Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
[TBL] [Abstract][Full Text] [Related]
2. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism.
Saini A; Al-Shanti N; Faulkner SH; Stewart CE
Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291
[TBL] [Abstract][Full Text] [Related]
3. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
Al-Shanti N; Saini A; Faulkner SH; Stewart CE
Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
5. C2 skeletal myoblast survival, death, proliferation and differentiation: regulation by Adra1d.
Saini A; Al-Shanti N; Stewart C
Cell Physiol Biochem; 2010; 25(2-3):253-62. PubMed ID: 20110686
[TBL] [Abstract][Full Text] [Related]
6. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
[TBL] [Abstract][Full Text] [Related]
7. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways.
Stewart CE; Newcomb PV; Holly JM
J Cell Physiol; 2004 Feb; 198(2):237-47. PubMed ID: 14603526
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L
Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768
[TBL] [Abstract][Full Text] [Related]
12. l-glutamine Improves Skeletal Muscle Cell Differentiation and Prevents Myotube Atrophy After Cytokine (TNF-α) Stress Via Reduced p38 MAPK Signal Transduction.
Girven M; Dugdale HF; Owens DJ; Hughes DC; Stewart CE; Sharples AP
J Cell Physiol; 2016 Dec; 231(12):2720-32. PubMed ID: 26991744
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 silencing confers neuroprotection through IGF-1 pathway activation.
Sansone L; Reali V; Pellegrini L; Villanova L; Aventaggiato M; Marfe G; Rosa R; Nebbioso M; Tafani M; Fini M; Russo MA; Pucci B
J Cell Physiol; 2013 Aug; 228(8):1754-61. PubMed ID: 23359486
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway.
Lin QQ; Yan CF; Lin R; Zhang JY; Wang WR; Yang LN; Zhang KF
Cytokine; 2012 Nov; 60(2):447-55. PubMed ID: 22717288
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 regulates the neurogenic potential of neural precursors in the adult subventricular zone and hippocampus.
Saharan S; Jhaveri DJ; Bartlett PF
J Neurosci Res; 2013 May; 91(5):642-59. PubMed ID: 23404532
[TBL] [Abstract][Full Text] [Related]
16. The role of resveratrol on skeletal muscle cell differentiation and myotube hypertrophy during glucose restriction.
Dugdale HF; Hughes DC; Allan R; Deane CS; Coxon CR; Morton JP; Stewart CE; Sharples AP
Mol Cell Biochem; 2018 Jul; 444(1-2):109-123. PubMed ID: 29189984
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis.
Mader I; Wabitsch M; Debatin KM; Fischer-Posovszky P; Fulda S
FASEB J; 2010 Jun; 24(6):1997-2009. PubMed ID: 20097879
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells.
Lee SJ; Kim MM
Life Sci; 2011 Mar; 88(11-12):465-72. PubMed ID: 21238464
[TBL] [Abstract][Full Text] [Related]
20. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
